 |
|
Analysis of Medication-Related Malpractice Claims
Causes, Preventability, and Costs
Jeffrey M. Rothschild, MD,MPH;
Frank A. Federico, RPh;
Tejal K. Gandhi, MD,MPH;
Rainu Kaushal, MD,MPH;
Deborah H. Williams, MHA;
David W. Bates, MD,MSc
Arch Intern Med. 2002;162:2414-2420.
Background Adverse drug events (ADEs) may lead to serious injury and may result in malpractice claims. While ADEs resulting in claims are not representative of all ADEs, such data provide a useful resource for studying ADEs. Therefore, we conducted a review of medication-related malpractice claims to study their frequency, nature, and costs and to assess the human factor failures associated with preventable ADEs. We also assessed the potential benefits of proved effective ADE prevention strategies on ADE claims prevention.
Methods We conducted a retrospective analysis of a New England malpractice insurance company claims records from January 1, 1990, to December 31, 1999. Cases were electronically screened for possible ADEs and followed up by independent review of abstracts by 2 physician reviewers (T.K.G. and R.K.). Additional in-depth claims file reviews identified potential human factor failures associated with ADEs.
Results Adverse drug events represented 6.3% (129/2040) of claims. Adverse drug events were judged preventable in 73% (n = 94) of the cases and were nearly evenly divided between outpatient and inpatient settings. The most frequently involved medication classes were antibiotics, antidepressants or antipsychotics, cardiovascular drugs, and anticoagulants. Among these ADEs, 46% were life threatening or fatal. System deficiencies and performance errors were the most frequent cause of preventable ADEs. The mean costs of defending malpractice claims due to ADEs were comparable for nonpreventable inpatient and outpatient ADEs and preventable outpatient ADEs (mean, $64 700-74 200), but costs were considerably greater for preventable inpatient ADEs (mean, $376 500).
Conclusions Adverse drug events associated with malpractice claims were often severe, costly, and preventable, and about half occurred in outpatients. Many interventions could potentially have prevented ADEs, with error proofing and process standardization covering the greatest proportion of events.
From the Division of General Medicine, the Department of Medicine, Brigham and Women's Hospital (Drs Rothschild, Gandhi, Kaushal, and Bates and Ms Williams), and the Risk Management Foundation of the Harvard Medical Institutions (Mr Federico), Boston, Mass.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Broadening the Business Case for Patient Safety
William B. Weeks and Amy E. Wallace
Arch Intern Med. 2003;163(9):1112.
EXTRACT
| FULL TEXT
Malpractice Claims Regarding Corticosteroids
Constantine John Falliers
Arch Intern Med. 2003;163(9):1112-1113.
EXTRACT
| FULL TEXT
Malpractice Claims Regarding Corticosteroids—Reply
Jeffrey M. Rothschild, Frank A. Federico, Tejal K. Gandhi, Deborah H. Williams, and David W. Bates
Arch Intern Med. 2003;163(9):1113.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Cost Implications of Reduced Work Hours and Workloads for Resident Physicians
Nuckols et al.
NEJM 2009;360:2202-2215.
ABSTRACT
| FULL TEXT
Electronic Health Records and Malpractice Claims in Office Practice
Virapongse et al.
Arch Intern Med 2008;168:2362-2367.
ABSTRACT
| FULL TEXT
Causes of preventable drug-related hospital admissions: a qualitative study
Howard et al.
Qual Saf Health Care 2008;17:109-116.
ABSTRACT
| FULL TEXT
Assessment of adverse drug events among patients in a tertiary care medical center
Johnston et al.
Am J Health Syst Pharm 2006;63:2218-2227.
ABSTRACT
| FULL TEXT
Clinical errors and medical negligence
Oyebode
Adv. Psychiatr. Treat. 2006;12:221-227.
ABSTRACT
| FULL TEXT
Risk of adverse drug events by patient destination after hospital discharge
Triller et al.
Am J Health Syst Pharm 2005;62:1883-1889.
ABSTRACT
| FULL TEXT
Risk Factors for Adverse Drug Events: A 10-Year Analysis
Evans et al.
The Annals of Pharmacotherapy 2005;39:1161-1168.
ABSTRACT
| FULL TEXT
Relationship between tort claims and patient incident reports in the Veterans Health Administration
Schmidek and Weeks
Qual Saf Health Care 2005;14:117-122.
ABSTRACT
| FULL TEXT
Error Reporting and Disclosure Systems: Views From Hospital Leaders
Weissman et al.
JAMA 2005;293:1359-1366.
ABSTRACT
| FULL TEXT
Organization and Representation of Patient Safety Data: Current Status and Issues around Generalizability and Scalability
Boxwala et al.
J. Am. Med. Inform. Assoc. 2004;11:468-478.
ABSTRACT
| FULL TEXT
Nursing and Midwifery Malpractice in Turkey Based on the Higher Health Council Records
Gundogmus et al.
Nurs Ethics 2004;11:489-499.
ABSTRACT
Learning from malpractice claims about negligent, adverse events in primary care in the United States
Phillips et al.
Qual Saf Health Care 2004;13:121-126.
ABSTRACT
| FULL TEXT
Broadening the Business Case for Patient Safety
Weeks and Wallace
Arch Intern Med 2003;163:1112-1112.
FULL TEXT
Malpractice Claims Regarding Corticosteroids
Falliers
Arch Intern Med 2003;163:1112-1113.
FULL TEXT
Evaluating the Impact of Information Technology on Medication Errors: A Simulation
Anderson et al.
J Am Med Inform Assoc 2003;10:292-293.
FULL TEXT
Evaluating the Impact of Information Technology on Medication Errors: A Simulation
Anderson et al.
J. Am. Med. Inform. Assoc. 2003;10:292-293.
FULL TEXT
|
